Rymarz Zdort Maruta with the full composition of Life Sciences & Compliance practice
12 February 2024
We are pleased to announce that the transfer of the Life Sciences & Compliance legal team to Rymarz Zdort Maruta has been completed. This extremely important change had already been announced in November, when Michał Czarnuch joined the law firm’s team as the head of the new practice. Michał will manage it the team along with the partners Dr Anna Partyka-Opiela, Marcin Pieklak and Tomasz Kaczyński.
“I am delighted that our team is now fully integrated with a law firm that sees and understands the demand among clients for services in the area of Life Sciences & Compliance and that wishes to offer such services as part of their plan to build a full-service law firm. We would like to thank our clients for the trust they have placed in us by deciding to embark on a new journey with us with Rymarz Zdort Maruta, and all of the staff and associates of the law firm for their warm welcome”, says Michał Czarnuch.
At the beginning of the year, the team was joined by:
Adam Ekk-Cierniakowski
+
Senior Associate, graduated from the Faculty of Law and Administration of the University of Szczecin. He gained his professional experience in Szczecin-based law firms and then in the Life Sciences practice of a leading Polish law firm. In his career, he has focused mainly on providing day-to-day legal support to pharmaceutical companies. He has also been involved in providing legislative and regulatory advice, including drafting opinions and proposals for amendments to draft legislation, and monitoring changes in laws and assessing their impact on business.
Dr Paweł Kaźmierczyk
+
Senior Associate, specialises in medical law, including the principles of conducting medical activities, practicing medical professions, patient rights and clinical trials, and also advises on legal issues related to telemedicine and e-health, artificial intelligence, and innovations in health care. Paweł is a member of the Committee of Experts on Health at the Ombudsman’s Office and a lecturer in postgraduate studies in medical law and the legal aspects of the use of new technologies in medicine, as well as a co-author of commentaries on acts in the field of medical law.
Paulina Kumkowska
+
Senior Associate, is an attorney-at-law and graduated from the Faculty of Law of the University of Warsaw. She also completed postgraduate studies in Intellectual Property Law. She gained her previous professional experience working in Warsaw-based law firms specialising in advising clients from the life sciences sector.
Patrick Wodecki
+
Senior Associate, is an advocate and graduated from the Faculty of Law and Administration of the University of Warsaw, as well as from the Institute of Philosophy of the University of Warsaw. He is currently working on his doctoral dissertation concerning the works of Fyodor Dostoevsky. He gained his professional experience working in the Life Sciences practice of a leading Polish law firm. In his career he has focused on advising entities operating in the pharmaceutical market engaged in both retail (pharmacy chains) and wholesale (manufacturers and pharmaceutical wholesalers) sales of medicinal products.
Hanna Bachowska
+
Associate, graduated from the University of Silesia, completed her traineeship as an advocate and defended her doctoral thesis in 2023. She gained her professional experience working in Polish law firms, where she focused on providing food law advice (including in respect of the marketing and advertising of dietary supplements) and supporting clients in reimbursement proceedings.
Jan Bednarski
+
Associate, graduated in law from the University of Wrocław and also holds a master’s degree in computer science and an engineering degree in automation and robotics from the Wrocław University of Technology. He also studied international technology law in Amsterdam (LL.M.). He gained his professional experience working in a Polish law firm, where he provided ongoing legal advice in the field of compliance, anticorruption, whistleblowing and pharmaceutical law.
Agata Cichocka
+
Associate, is an advocate trainee and graduated with a master’s degree from the Faculty of Law and Administration of Cardinal Stefan Wyszynski University in Warsaw. In her career, she has focused on advising businesses operating in the food and pharmaceutical market, in particular in connection with ensuring access to therapies and reimbursement.
Magdalena Krupa
+
Associate, holds a master’s degree in law and a bachelor’s degree in intellectual property and new media law from Jagiellonian University, and is currently pursuing postgraduate studies in animal rights. She gained her previous professional experience in law firms specialising in life sciences.
Julia Nowosielska-Łaskawiec
+
Associate, is an advocate trainee and graduated from the Faculty of Law and Administration at Cardinal Stefan Wyszyński University in Warsaw. She also holds an engineering degree in Chemical Technology from the Faculty of Chemistry at the Warsaw University of Technology. She gained her professional experience working in the Life Sciences team of a leading Polish law firm. In her career, she has focused on serving clients in the areas of distribution of medicinal products, and regulated activities in the pharmaceutical market.
Maria Papis
+
Associate, is a trainee attorney-at-law and graduated from the Faculty of Law and Administration of the University of Warsaw. She gained her professional experience working in law firms and in the in-house legal departments of the pharmaceutical companies AstraZeneca and Polpharma. She advises clients in the areas of life sciences (pharmaceutical and cosmetics law), compliance, whistleblowing and ESG, with an emphasis on governance aspects.
Paweł Mirosz
+
Expert, is a bromatologist specialising in legal consulting on food quality and safety. He gained his professional experience in the National Food and Nutrition Institute, the State Sanitary Inspectorate, the Polish Focal Point of the European Food Safety Authority and top food law consulting companies in Poland. He is a lecturer and author of many publications concerning the standards and practice of food law.
“Expanding the range of services provided by our law firm is one of the key elements of our strategy. We are very pleased to be joined by such a renowned team of experienced lawyers in this area. I am confident that with the addition of a fifteen-strong team of Life Sciences & Compliance specialists, combined with the rest of our firm’s leading practices, we will set new standards for the quality of legal advice in this field”, concludes Paweł Zdort, managing partner.
Fot. Bartosz Maciejewski
More news
Rymarz Zdort Maruta advises Vantage on raising EUR 100 million in financing from EBRD for construction of rental flats
18 November 2024
We are pleased to announce that Rymarz Zdort Maruta advised Vantage, a company that develops and manages a PRS platform, belonging together with ROBYG to the TAG Immobilien group, in connection with s...
Important judgment of Court of Conciliation for Internet Domains at PIIT concerning desa.pl domain name
12 November 2024
We are pleased to announce that our law firm successfully represented DESA Unicum S.A. before the Internet Domain Arbitration Court at the Polish Chamber of Information Technology and Telecommunicatio...
Rymarz Zdort Maruta advises Sanok Rubber Company S.A. in connection with PFR TFI's investment in Teknikum-Yhtiöt Oy
12 November 2024
We are pleased to announce that we provided legal support to Sanok Rubber Company S.A. (the “Company”) in connection with the signing of an investment agreement with PFR TFI-managed Fundusz Ekspansji ...
Rymarz Zdort Maruta advises Mutares on acquisition of Natura
7 November 2024
We are pleased to announce that we advised Mutares SE & Co. KGaA (“Mutares”) on the acquisition of Natura sp. z o.o. (“Natura”), one of the largest and longest operating cosmetics store chains on ...
Rymarz Zdort Maruta advises EWE AG on sale of EWE Polska to Elenger/Eesti Gaas
5 November 2024
We are pleased to announce that we advised EWE AG on the sale of EWE Polska, the second largest privately-owned natural gas network operator in Poland, to Eesti Gaas, operating in export markets under...
Rymarz Zdort Maruta advises on sale of Noble Securities to Skarbiec Holding
4 November 2024
We are pleased to announce that we advised the bankruptcy trustee of Getin Noble Bank (the “Bankruptcy Trustee”) on the sale of a 100% interest in Noble Securities (the “Company”) to Skarbiec Holding....
Rymarz Zdort Maruta advises LifeSpot on PRS market transaction worth approximately PLN 59 million
4 November 2024
We are pleased to announce that we advised LifeSpot, a long-term housing rental platform in Poland managed by Griffin Capital Partners, on their purchase, from Cavare S.A., of a project being dev...
Rymarz Zdort Maruta advises on sale of Noble Funds TFI to VeloBank
28 October 2024
We are pleased to announce that we advised the bankruptcy trustee of Getin Noble Bank and Idea Bank on the sale of a total holding of approximately 86.83% of the shares in Noble Funds TFI, a fund mana...
Rymarz Zdort Maruta among best law firms according to IFLR1000 2024 ranking
24 October 2024
We are pleased to announce that in the most recent edition of the IFLR1000 2024 ranking, our law firm has once again been recognised as one of the best law firms in Polan...
A revolution in healthcare: The growing importance of e-commerce as part of the digital transformation of the healthcare system
18 September 2024
Pharmaceutical e-commerce is a key element of the digital transformation of the healthcare system, a process that has accelerated in recent years. In 2023, the value of sales in the Polish e-pharmacy ...
Rymarz Zdort Maruta advises Arcus Infrastructure Partners on acquisition of FixMap
17 September 2024
We are pleased to announce that we advised Arcus Infrastructure Partners (“Arcus”), an infrastructure fund, on the purchase of FixMap sp. z o.o. (“FixMap”), a Polish fibre-to-the-home business. As a r...
Rymarz Zdort Maruta advises AFI Europe on purchase of land in Wrocław valued at PLN 50.5 million
30 August 2024
We are pleased to announce that we advised AFI Europe, an international investor operating office, commercial, and residential projects in Central and Eastern Europe, on the purchase from De...